Seoul National University Hospital
Seoul, South Korea
NCT Number: NCT03715712
This study compares the effect of individualized vs standard blood pressure management on postoperative myocardial injury in high-risk patients undergoing non-cardiac surgery by measuring the hs-cTnT levels. Continuous norepinephrine infusion is used to target a mean pressure of greater than 65mmHg and a systolic pressure less than 160mmHg in the standardized group while the target is 20% within the ward blood pressure in the individualized group. The pre- and postoperative hs-cTnT levels to detect myocardial injury are compared between the two groups.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Seoul, South Korea
Managing the blood pressure preoperatively is important in high-risk patients because hypotension can lead to perioperative myocardial injury. It has been reported that a systolic pressure of less than 50-55mmHg or greater than 40% decrease can lead to cardiac complications. The mechanism of hypotension leading to postoperative myocardial injury is due to hypoperfusion and ischemic reperfusion injury.
In this randomized controlled study, the blood pressure for participants in the standardized group is maintained as follows: mean blood pressure greater than 65mmHg and systolic blood pressure less than 160mmHg. The individualized group participants' blood pressure is maintained at a target of 20% within the preoperative ward blood pressure. Anesthesia and intraoperative management are the same in both groups to target a bispectral index level of 50. In order to quantitatively measure the myocardial injury, high sensitive cardiac troponin T (hs-cTnT) will be measured pre- and postoperatively. A level greater than 14ng/dl has been reported to be associated with myocardial injury and mortality. The objective of this study is to show that the standardized protocol of maintaining a mean pressure greater than 65mmHg is non inferior to the individualized management in terms of postoperative myocardial injury.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standardized blood pressure management of a mean blood pressure > 65mmHg and a systolic blood pressure of < 160mmHg using norepinephrine continuous infusion
Individualized blood pressure management of 20% within the preoperative ward blood pressure using norepinephrine continuous infusion
Time frame: baseline and postoperative day 1
the change of hs-cTnT levels
Time frame: 1 month
hospital length of stay
Time frame: 1 month
ICU length of stay
Time frame: 1 month
in hospital mortality
Time frame: intraoperative
total amount of norepinephrine used
Time frame: intraoperative
blood pressure, heart rate, ECG, stroke volume, stroke volume variation, bispectral index
Time frame: 1 month
chest pain, dyspnea, edema, acute coronary syndrome
Time frame: postoperative 48 hours
serum creatinine increase and urine output
Seoul National University Hospital
Other
Comparison of Individualized vs Standard Blood Pressure Target on the Postoperative Myocardial Injury in High Risk Patients Undergoing Non-cardiac Surgery- a Randomized Non-inferiority Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07386990
Cardioplegia, Cardiopulmonary Bypass
Lund, Sweden
View Trial DetailsNCT06753461
Cardiovascular Diseases, Hypotension
View Trial DetailsNCT02687776
Diabetes Insipidus, Endocrine System Diseases
Düsseldorf, Germany
View Trial DetailsNCT01850927
Perioperative Myocardial Injury
Reading, Berks, United Kingdom
View Trial Details